Athira Pharma Inc
Biotechnology
Healthcare
ATHA
39.09 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
3.86
52 week high
4.21
high
4.49
52 week low
0.00
low
3.86
growth
8.79 %
previous Close
3.86
P/E ratio
-2
market cap
15.11 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-6.97 M
23.81 %
eps
-1.80 %
-682.61 %
eps surprise
-718.18 %
net profit margin
-696600000.00 %
0.00 %
operating incoming
-7.29 M
23.54 %
net change in cash
-6.53 M
70.32 %
cash on hand
19.89 M
-24.73 %
cost of revenue
200 K
-17.70 %
top top